Outcomes of bariatric surgery for patients with prevalent inflammatory bowel disease: A nationwide registry-based cohort study.

BACKGROUND: Obesity is becoming more prevalent in patients with inflammatory bowel disease. Although bariatric surgery is an effective treatment for obesity, questions remain regarding its safety and effectiveness for patients with inflammatory bowel disease. The aim of this study was to evaluate the safety and effectiveness of bariatric surgery in patients with inflammatory bowel disease. METHOD: This registry-based, propensity-matched cohort study included all patients who had primary Roux-en-Y gastric bypass or sleeve gastrectomy in Sweden from January 2007 to June 2020 who had an inflammatory bowel disease diagnosis and matched control patients without an inflammatory bowel disease diagnosis. The study included data from the Scandinavian Obesity Surgery Registry, the National Patient Register, the Swedish Prescribed Drugs Register, the Total Population Register, and the Education Register from Statistics Sweden. RESULTS: In total, 71,093 patients who underwent bariatric surgery, including 194 with Crohn's disease and 306 with ulcerative colitis, were 1:5 matched to non-inflammatory bowel disease control patients. The patients with Crohn's disease had a higher readmission rate within 30 days (10.7% vs 6.1%, odds ratio = 1.84, 95% confidence interval 1.02-3.31) than the control patients, with no significant difference between the surgical methods. The patients with ulcerative colitis had a higher risk for serious postoperative complications after Roux-en-Y gastric bypass (8.0% vs 3.7%, odds ratio = 2.64, 95% confidence interval 1.15-6.05) but not after sleeve gastrectomy compared to control patients (0.8% vs 2.3%). No difference was observed in postoperative weight loss or postoperative health-related quality of life. CONCLUSION: Sleeve gastrectomy appears to be a safe and effective treatment for obesity in patients with inflammatory bowel disease, whereas Roux-en-Y gastric bypass was associated with a higher risk for postoperative complications in patients with ulcerative colitis.

Comparison of the subjective sense of high or low metabolism and objectively measured resting metabolic rate.

OBJECTIVE: To measure caloric intake, physical activity level and resting metabolic rate in participants having the subjective opinion of either having a high or low metabolic rate. METHODS: Recruitment by local advertising of healthy subjects feeling that they have high or low metabolism, i.e. either a tendency to easily stay lean ('high') or to very easily gain weight ('low') also when taking food intake in comparison with physical activity into account. Walking distance was estimated by pedometry, assessment of caloric intake was determined by food registration. Measurement of resting metabolic rate was performed in the fasting state. RESULTS: We recruited 44 participants with a sense of 'high' metabolism and 12 subjects in the contrasting group. Subjects with 'high' metabolism were leaner ('high': 20.4 +/- 2.1 kg/m(2), 'low': 27.8 +/- 7.5 kg/m(2), p < 0.0001) and reported a higher caloric intake than those with 'low' metabolism ('high': 11435 +/- 2420 kJ/24 h, 'low': 8339 +/- 2679 kJ/24 h, p = 0.001). Despite this there was no difference in the measured resting metabolic rate between the two groups ('high': 7230 +/- 1233 kJ/24 h, 'low': 7430 +/- 1422 kJ/24 h, p = 0.6), nor was there any difference in physical activity measured by pedometry. Resting metabolic rate was negatively correlated with age and positively correlated with BMI in multivariate analyses of the total cohort. CONCLUSION: The sense of having a low or high metabolic rate is not related to actual resting metabolic rate.